Kardigan
- Health & Biotech
- South San Francisco, CA, US
- Founded 2023
- Public
- kardigan.bio
Heart health company developing precision cardiovascular medicines for dilated cardiomyopathy, aortic valve stenosis and acute severe hypertension.
$554MEquity raised in 2025–20262025 $554M · 2026 — · 2 equity rounds
$554MEquity raised, all time2 equity rounds sourced so far
—Latest valuationnot disclosed
Rounds over time log-scaled amounts
Funding history 2 rounds · 4 sources · newest first
Earlier rounds not yet sourced. Kardigan was founded in 2023 and raised before 10 Jan 2025; only the rounds below are sourced so far, so its all-time equity total understates its history.
- Series BAmount$254MPost-money—✓ Confirmed
- Series AAmount$300MPost-money—✓ Confirmed
- Earlier rounds not yet sourced
Investors 5
- ARCH Venture Partners2
- Sequoia Capital2
- Perceptive Advisors1
- Fidelity
- T. Rowe Price
Highlighted investors led at least one equity round; the number is equity rounds taken part in.
Related companies shared investors
AnthropicAI Labs · $113B in 2025–2026Shared: Sequoia Capital, Fidelity +1WaymoRobotics · $16B in 2025–2026Shared: Sequoia Capital, Fidelity +1Parabilis MedicinesHealth · $975M in 2025–2026Shared: ARCH Venture Partners, Fidelity +1RampFintech · $3.6B in 2025–2026Shared: Sequoia Capital, Fidelity +1FalAI Infra · $1.9B in 2025–2026Shared: Sequoia Capital, T. Rowe PriceHarveyAI Apps · $1.6B in 2025–2026Shared: Sequoia Capital, T. Rowe Price
Also in the South San Francisco hub see on the globe
Figures in USD at the time of each round. See the methodology for how rounds are sourced and verified. Kardigan and its logo are trademarks of their owners, used here for identification only.
